Cancer risk with alemtuzumab following kidney transplantation

Analyzing Competing Risk Data Using theRtimeregPackage

(2015) Thomas H. Scheike et al.   Journal of Statistical Software

Spectrum of Cancer Risk Among US Solid Organ Transplant Recipients

(2011) Eric A. Engels et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Alemtuzumab Induction in Renal Transplantation

(2011) Michael J. Hanaway et al.   NEW ENGLAND JOURNAL OF MEDICINE

Comparison of the Incidence of Malignancy in Recipients of Different Types of Organ: A UK Registry Audit

(2010) D. Collett et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Cancer incidence and risk factors after solid organ transplantation

(2009) Claire M. Vajdic et al.   INTERNATIONAL JOURNAL OF CANCER

A Randomized Trial of Alemtuzumab Versus Antithymocyte Globulin Induction in Renal and Pancreas Transplantation

(2009) Alan C. Farney et al.   TRANSPLANTATION

Alemtuzumab (Campath-1H) and Tacrolimus Monotherapy After Renal Transplantation: Results of a Prospective Randomized Trial

(2008) R. Margreiter et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Molecular and Immunologic Mechanisms of Cancer Pathogenesis in Solid Organ Transplant Recipients

(2008) O. M. Martinez et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Predicting cumulative incidence probability by direct binomial regression

(2008) T. H. Scheike et al.   BIOMETRIKA

Campath Induction for Kidney Transplantation: Report of 297 Cases

(2008) Jorge Ortiz et al.   TRANSPLANTATION